Chemours Co reports fourth-quarter results Thursday, with investors weighing management’s path to recovery against expectations for another challenging quarter. Analysts expect earnings of 7 cents per ...

I rate Tronox as a HOLD due to near-term demand weakness in TiO2, margin pressures, and free cash flow concerns despite long-term tailwinds. Recent earnings disappointed, with negative surprises, ...

Tronox (NYSE:TROX) -0.3% in choppy trading Friday as J.P. Morgan downgraded shares to Neutral from Overweight, saying conditions in the titanium dioxide industry have become more difficult in the near ...

THOOTHUKUDI: Titanium dioxide (TiO2) pigment manufacturers are reeling under an acute shortage of ilmenite, the key raw ...

Nanoparticle research presents wide scope for the development of novel solutions in the field of healthcare, cosmetics, optics and electronics. Altering their molecular and atomic states results in ...

The European Commission has determined that there are no viable alternatives to titanium dioxide (TiO2) as an excipient in many pharmaceutical products. They also identified a risk of shortages if a ...